Literature DB >> 16522840

Lessons from and cautions about noninferiority and equivalence randomized trials.

Peter C Gøtzsche.   

Abstract

Mesh：

Year:  2006        PMID： 16522840     DOI： 10.1001/jama.295.10.1172

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  26 in total

Review 1.  Understanding equivalence and noninferiority testing.

Authors:  Esteban Walker; Amy S Nowacki
Journal:  J Gen Intern Med       Date:  2010-09-21       Impact factor: 5.128

Review 2.  Plea of the defence-critical comments on the interpretation of EVA3S, SPACE and ICSS.

Authors:  Jens Fiehler; Søren Jacob Bakke; Andrew Clifton; Emmanuel Houdart; Olav Jansen; Daniel Rüfenacht; Michael Söderman; Christophe Cognard
Journal:  Neuroradiology       Date:  2010-05-04       Impact factor: 2.804

3.  What's new in trial design: propensity scores, equivalence, and non-inferiority.

Authors:  Paul S Myles
Journal:  J Extra Corpor Technol       Date:  2009-12

4.  Comment by J. Schäfer, G. Welzel, F. Wenz on D. Norkus et al. A randomized trial comparing hypofractionated and conventionally fractionated three-dimensional external-beam radiotherapy for localized prostate adenocarcinoma. a report on acute toxicity : in: Strahlenther Onkol 2009;185: 715-21 (No. 11) (DOI 10.1007/s00066-009-1982-z).

Authors:  Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2009-11       Impact factor: 3.621

5.  Design and interpretation of non-inferiority studies: A clinician's perspective.

Authors:  Todd M Brown
Journal:  J Nucl Cardiol       Date:  2017-08-10       Impact factor: 5.952

6.  Safety of aspiration abortion performed by nurse practitioners, certified nurse midwives, and physician assistants under a California legal waiver.

Authors:  Tracy A Weitz; Diana Taylor; Sheila Desai; Ushma D Upadhyay; Jeff Waldman; Molly F Battistelli; Eleanor A Drey
Journal:  Am J Public Health       Date:  2013-01-17       Impact factor: 9.308

Review 7.  Drug development: how academia, industry and authorities interact.

Authors:  Silvio Garattini; Norberto Perico
Journal:  Nat Rev Nephrol       Date:  2014-08-05       Impact factor: 28.314

8.  Design of non-inferiority randomized trials using the difference in restricted mean survival times.

Authors:  Isabelle R Weir; Ludovic Trinquart
Journal:  Clin Trials       Date:  2018-08-03       Impact factor: 2.486

9.  Adenosine versus regadenoson comparative evaluation in myocardial perfusion imaging: results of the ADVANCE phase 3 multicenter international trial.

Authors:  Ami E Iskandrian; Timothy M Bateman; Luiz Belardinelli; Brent Blackburn; Manuel D Cerqueira; Robert C Hendel; Hsiao Lieu; John J Mahmarian; Ann Olmsted; S Richard Underwood; João Vitola; Whedy Wang
Journal:  J Nucl Cardiol       Date:  2007 Sep-Oct       Impact factor: 5.952

10.  Modified intention to treat reporting in randomised controlled trials: systematic review.

Authors:  Iosief Abraha; Alessandro Montedori
Journal:  BMJ       Date:  2010-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.